These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 33878914)

  • 21. Volume-to-creatinine clearance ratio in patients undergoing coronary angiography with or without percutaneous coronary intervention: implications of varying definitions of contrast-induced nephropathy.
    Capodanno D; Ministeri M; Cumbo S; Dalessandro V; Tamburino C
    Catheter Cardiovasc Interv; 2014 May; 83(6):907-12. PubMed ID: 23934631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the risk factors for contrast-induced nephropathy in over-aged patients receiving coronary intervention.
    Pan HC; Wu XH; Wan QL; Liu And BH; Wu XS
    Exp Biol Med (Maywood); 2018 Aug; 243(12):970-975. PubMed ID: 30299175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Risk factors and scoring system in the prediction of contrast induced nephropathy in patients undergoing percutaneous coronary intervention].
    Fu NK; Yang SC; Chen YL; Xu J; Li Q; Li XM; Liu YY; Liu XG; Cong HL
    Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(8):551-4. PubMed ID: 22490160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pre-diabetes and the risk of contrast induced nephropathy in patients undergoing coronary angiography or percutaneous intervention.
    Barbieri L; Verdoia M; Schaffer A; Cassetti E; Di Giovine G; Marino P; Suryapranata H; De Luca G
    Diabetes Res Clin Pract; 2014 Dec; 106(3):458-64. PubMed ID: 25458324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum osmolarity as a potential predictor for contrast-induced nephropathy following elective coronary angiography.
    Kanbay M; Siriopol D; Ozdogan E; Afsar B; Ertuglu LA; Grigore M; Sag AA; Kuwabara M; Lanaspa MA; Ortiz A; Johnson RJ; Covic A
    Int Urol Nephrol; 2020 Mar; 52(3):541-547. PubMed ID: 32008199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Female gender and contrast-induced nephropathy in primary percutaneous intervention for ST-segment elevation myocardial infarction.
    Lucreziotti S; Centola M; Salerno-Uriarte D; Ponticelli G; Battezzati PM; Castini D; Sponzilli C; Lombardi F
    Int J Cardiol; 2014 Jun; 174(1):37-42. PubMed ID: 24698233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation of uric acid and contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention in the ED.
    Saritemur M; Turkeli M; Kalkan K; Tanboga İH; Aksakal E
    Am J Emerg Med; 2014 Feb; 32(2):119-23. PubMed ID: 24238488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic immune-inflammation index associated with contrast-induced nephropathy after elective percutaneous coronary intervention in a case-control study.
    Ma X; Mo C; Li Y; Gui C
    Coron Artery Dis; 2023 Sep; 34(6):432-440. PubMed ID: 37222216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contrast Volume-to-Creatinine Clearance Ratio Predicts the Risk of Contrast-Induced Nephropathy After Percutaneous Coronary Intervention in Patients With Reduced Ejection Fraction.
    Liu Y; Chen SQ; Duan CY; Tan N; Chen JY; Zhou YL; Chen PY; Huang SJ; Liu XQ
    Angiology; 2015 Aug; 66(7):625-30. PubMed ID: 25158831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrast Media Volume to Creatinine Clearance Ratio in Predicting Nephropathy in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
    Nie Y; Fan L; Song Q; Wu F
    Angiology; 2023 Jul; 74(6):545-552. PubMed ID: 35815550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of vascular access on the development of contrast induced nephropathy in patients undergoing coronary angiography and/or percutaneous coronary intervention.
    Barbieri L; Verdoia M; Suryapranata H; De Luca G;
    Int J Cardiol; 2019 Jan; 275():48-52. PubMed ID: 30274753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated high-sensitivity C-reactive protein combined with procalcitonin predicts high risk of contrast-induced nephropathy after percutaneous coronary intervention.
    Gu G; Yuan X; Zhou Y; Liu D; Cui W
    BMC Cardiovasc Disord; 2019 Jun; 19(1):152. PubMed ID: 31234798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors and clinical outcomes for contrast-induced nephropathy after percutaneous coronary intervention in patients with normal serum creatinine.
    Chong E; Poh KK; Liang S; Tan HC
    Ann Acad Med Singap; 2010 May; 39(5):374-80. PubMed ID: 20535427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Chronic Statin Therapy on Postprocedural Contrast-Induced Nephropathy in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention.
    Chanin JM; Yang DC; Haider MA; Swaminathan RV; Kim LK; Charitakis K; Tanoue M; Minutello RM; Gade CL; Singh HS; Bergman G; Wong SC; Feldman DN
    J Invasive Cardiol; 2015 Nov; 27(11):490-6. PubMed ID: 25999136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction.
    Mager A; Vaknin Assa H; Lev EI; Bental T; Assali A; Kornowski R
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):198-201. PubMed ID: 20949583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Neutrophil-to-lymphocyte Ratio with Contrast-induced Nephropathy in Patients with Non-ST-elevation Acute Coronary Syndrome Treated with Percutaneous Coronary Intervention.
    Kurtul A; Yarlioglues M; Duran M; Murat SN
    Heart Lung Circ; 2016 Jul; 25(7):683-90. PubMed ID: 26935164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between red cell distribution width and contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention.
    Akkoyun DÇ; Akyüz A; Kurt Ö; Bilir B; Alpsoy Ş; Güler N
    Turk Kardiyol Dern Ars; 2015 Oct; 43(7):613-20. PubMed ID: 26536986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk Factors of Contrast-induced Acute Kidney Injury in Patients Undergoing Emergency Percutaneous Coronary Intervention.
    Yuan Y; Qiu H; Hu XY; Luo T; Gao XJ; Zhao XY; Zhang J; Wu Y; Yan HB; Qiao SB; Yang YJ; Gao RL
    Chin Med J (Engl); 2017 5th Jan 2017; 130(1):45-50. PubMed ID: 28051022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uric acid levels and the risk of Contrast Induced Nephropathy in patients undergoing coronary angiography or PCI.
    Barbieri L; Verdoia M; Schaffer A; Cassetti E; Marino P; Suryapranata H; De Luca G;
    Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):181-6. PubMed ID: 25315668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention without acute left ventricular ejection fraction impairment.
    Pyxaras SA; Sinagra G; Mangiacapra F; Perkan A; Di Serafino L; Vitrella G; Rakar S; De Vroey F; Santangelo S; Salvi A; Toth G; Bartunek J; De Bruyne B; Wijns W; Barbato E
    Am J Cardiol; 2013 Mar; 111(5):684-8. PubMed ID: 23261003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.